ADVERTISEMENTREMOVE AD

With Over 1.25 Billion Jabs in India, SII Seeks Full Approval for Covishield

With supplies of Covishield exceeding 1.25 billion doses, there is enough data for full market approval, says SII.

Published
story-hero-img
i
Aa
Aa
Small
Aa
Medium
Aa
Large

Serum Institute of India (SII) chief Adar Poonawalla, on Friday, 31 December, announced that the firm had applied to the country's drug regulator and the Health Ministry for full authorisation for its COVID-19 vaccine, Covishield.

Poonawalla said that with supplies of Covishield in India exceeding 1.25 billion doses, the government of India had enough data for full market authorisation.

SII had been granted emergency approval in India for Covishield earlier this year.

Speaking truth to power requires allies like you.
Become a Member
Monthly
6-Monthly
Annual
Check Member Benefits
×
×